Published 1 year ago

Fosun weighs sale of Indian drugmaker Gland Pharma

Summary by Ground News

Shanghai Fosun Pharmaceutical Group Co Ltd is considering a sale of Indian drugmaker Gland Pharma Ltd. Gland has a market value of $3.5 billion, according to Bloomberg. Fosin holds a 57.86 per cent stake in Gland.

0 Articles

All

Left

Center

Right

Reuters

Fosun weighs sale of Indian drugmaker Gland Pharma

China's Shanghai Fosun Pharmaceutical Group Co Ltd is considering a sale of Indian drugmaker Gland Pharma Ltd , Bloomberg News reported on Tuesday, citing people familiar with the matter.

1 year ago·United Kingdom

Read Full Article

South China Morning Post

Fosun mulls sale of Indian drug maker Gland valued at US$3.6 billion

A sale of Hyderabad-based Gland, which specialises in injectable drugs such as antibiotics, oncology and cardiology treatments, will help Fosun raise cash and shore up its balance sheet.

1 year ago·Hong Kong

Read Full Article

Channel News Asia

Fosun weighs sale of Indian drugmaker Gland Pharma

BENGALURU :China's Shanghai Fosun Pharmaceutical Group Co Ltd is considering a sale of Indian drugmaker Gland Pharma Ltd, Bloomberg News reported on Tuesday, citing people familiar with the matter.Fosun, which holds a 57.86 per cent stake in Gland Pharma, did not immediately respond to Reuters' request for co

1 year ago·Singapore

Read Full Article

Bloomberg

Fosun Said to Mull Sale of India’s $3.6 Billion Gland Pharma

Billionaire Guo Guangchang’s Shanghai Fosun Pharmaceutical Group Co. is considering a sale of Indian drugmaker Gland Pharma Ltd. after receiving interest from potential buyers, people familiar with the matter said.

1 year ago·United States

Read Full Article

Business Standard

Fosun reportedly planning sale of India's $3.6 billion Gland Pharma

Fosun Pharma, a listed arm of Chinese conglomerate Fosun International Ltd., has been working with an adviser as it informally gauges interest in its controlling stake in Gland

1 year ago·India

Read Full Article